Diabetic ketoacidosis and persistent hyperglycemia as long-term complications of L-asparaginase-induced pancreatitis

Chinese Medical Journal (Taipei)

Volumn 65, Issue 9, 2002, Pages 441-445

  Hsu, Yu Juei ^a   Chen, Yeu Chin ^a   Ho, Ching Liang ^a   Kao, Woei Yau ^a   Chao, Tsu Yi ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

Asparaginase; Diabetic Ketoacidosis; Hyperglycemia; Pancreatitis

Indexed keywords

ANTIBIOTIC AGENT; ASPARAGINASE; GLUCOSE; INSULIN; ORAL ANTIDIABETIC AGENT;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; CANCER GROWTH; CANCER RECURRENCE; CASE REPORT; CAUSE OF DEATH; DEATH; DIABETIC KETOACIDOSIS; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HEMATOLOGIC MALIGNANCY; HUMAN; HYPERGLYCEMIA; MALE; PANCREAS PSEUDOCYST; PANCREATITIS; RISK FACTOR; SEPSIS;

ADULT; ANTINEOPLASTIC AGENTS; ASPARAGINASE; DIABETIC KETOACIDOSIS; HUMANS; HYPERGLYCEMIA; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; PANCREATITIS;

EID: 0036758271     PISSN: 05781337     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Land VJ, Sutow WW, Fernbach DJ, Lane DM, Williams TE. Toxicity of L-asparaginase in children with advanced leukemia. Cancer 1972;30:339-47.
2. Cetin M, Yetgin S, Kara A, Tuncer M, Günay M, Gümrük F, et al. Hyperglycemia, ketoacidosis and other complications of L-asparaginase in children with acute lymphoblastic leukemia. J Med 1994;25:219-29.
3. Gillette PC, Hill LL, Starling KA, Fernbach DJ. Transient diabetes mellitus secondary to L-asparaginase therapy in acute leukemia. J Pediatr 1972;81:109-11.
4. Gailani S, Nussbaum BS, Ohnuma T, Freeman A. Diabetes in patients treated with asparaginase. Clin Pharmacol Ther 1971;12:487-90.
5. Iyer RS, Rao SR, Pai S, Advani SH, Magrath IT. L-asparaginase related hyperglycemia. Indian J Cancer 1993;30:72-6.
6. McLean R, Martin S, Lam-Po-Tang PRL. Fatal case of L-asparaginase induced pancreatitis. Lancet 1982;2:1401-2.
7. Pui CH, Burghen GA, Bowman WP, Aur RJA. Risk factors for hyperglycemia in children with leukemia receiving L-asparaginase and prednisolone. J Pediatr 1981;99:46-50.
8. Summerfield G, Swirsky D. Side effects of colaspase. Br Med J 1978;2:1373-4.
9. Sahu S, Saika S, Pai SK, Advani SH. L-asparaginase (Leunase) induced pancreatitis in childhood acute lymphoblastic leukemia. Pediatr Hematol Oncol 1998;15:533-8.
10. Varsano L, Zaizov R, Nitzan M. Persistent diabetes and ketoacidosis due to L-asparaginase therapy. Helv Paediatr Acta 1973;28:365-9.
11. Wang YJ, Chu HY, Shu SG, Chi CS. Hyperglycemia induced by chemotherapeutic agents used in acute lymphoblastic leukemia: report of three cases. Chin Med J (Taipei) 1993;51:457-61.
12. Yu CH, Lin KH, Lin DT, Chen RL, Horng YC, Chang MH. L-asparaginase-related pancreatic pseudocyst: report of a case. J Formos Med Assoc 1994;93:441-4.
13. Rovira A, Cordido F, Vecilla C, Bernacer M, Valverde I, Pombo H. Study of beta-cell function and erythrocyte insulin receptors in a patient with diabetic ketoacidosis associated with L-asparaginase therapy. Acta Paediatr Scand 1986;75:670-1.
14. Falletta JM, Steuber CP, Hayes JW, Starling KA, Hill LL. Nonketotic hyperglycemia due to prednisolone following ketotic hyperglycemia due to L-asparaginase plus prednisolone. Cancer Chemother Rep 1972;56:781-2.
15. Rao SP, Castells S. Hyperglucagonemia in L-asparaginase induced diabetes mellitus. Am J Pediatr Hematol Oncol 1986;8:83-5.
16. Muller HJ, Boos J. Use of L-asparaginase in childhood ALL. Crit Rev Oncol Hematol 1998;28:97-113.
17. Dacou-Voutetakis C, Palis J, Haidas S, Zannos-Moriolea L. Abnormal glucose tolerance in children with acute leukemia: effect of induction chemotherapy including L-asparaginase. Am J Pediatr Hematol Oncol 1983;5:139-46.
18. Ridgway D, Neerhout RC, Bleyer A. Attenuation of asparaginase-induced hyperglycemia after substitution of the Erwinia carotovora for Escherichia coli enzyme preparation. Cancer 1989;63:561-3.